special populations and immune checkpoint inhibitors: are they safe?
Published 1 month ago • 2 plays • Length 31:26Download video MP4
Download video MP3
Similar videos
-
14:32
evaluating the use of immune checkpoint inhibitors in melanoma
-
55:18
immunotherapy in special populations with non-small cell lung cancer: what would the oncologist do?
-
40:21
extending horizons with immune checkpoint inhibitors in small cell lung cancer: 2022 perspectives
-
29:56
expert insights into the biosafety of oncolytic immunotherapies and their combination with immune...
-
29:57
immune checkpoint inhibitors with dr. kerry reynolds
-
5:33
cancer immune checkpoint inhibitors
-
1:50
immune checkpoint inhibitors
-
17:14
cardiovascular toxicity and immune checkpoint inhibitors
-
14:42
managing toxicities associated with immune-checkpoint inhibitors
-
30:23
lecture looking ahead - potential barriers to immune checkpoint inhibitors use in mibc
-
40:28
meeting of the minds: addressing the gray zone of immunotherapy for advanced non-small cell lung ...
-
45:59
immune checkpoint inhibitors in solid tumours
-
7:25
how to manage toxicities from immune checkpoint inhibitors?
-
5:10
introduction to immune checkpoint inhibitor (ici) immunotherapy
-
27:43
targeting the immune system with checkpoint inhibitors
-
1:20
resistance to immune checkpoint blockade in patients with cscc
-
1:01:45
immune checkpoint inhibitors: the good, the bad, and the emerging field of cardio-oncology
-
1:50
what are 'checkpoint' immunotherapy drugs? | immunotherapy | cancer research uk
-
1:37:30
enhancing the treatment of hr nmibc with immunotherapy-based regimens_366418.06